Keisuke Onishi, Representative Director and President
Received his Ph.D. from the School of Engineering in The University of Tokyo. Worked on his post-doctoral research in basic research in neuroscience at the University of California, San Diego from 2010 for 9 years. Joined the Research and Development Department of our company in 2019. Discovered a new therapeutic candidate for the treatment of COVID-19 at the end of January 2021. Appointed representative director and president of our company at the end of June 2023. Believes in the potential of regenerative medicine and is committed to developing new treatments to bring smiles to patients suffering from diseases, their families, and individuals around the world.